Market Overview

How Does AstraZeneca's Debt Look?


Over the past three months, shares of AstraZeneca Inc. (NYSE: AZN) rose by 7.70%. Before we understand the importance of debt, let's look at how much debt AstraZeneca has.

AstraZeneca's Debt

Based on AstraZeneca’s financial statement as of July 28, 2016, long-term debt is at $16.95 billion and current debt is at $2.06 billion, amounting to $19.00 billion in total debt. Adjusted for $3.92 billion in cash-equivalents, the company's net debt is at $15.09 billion.

To understand the degree of financial leverage a company has, investors look at the debt ratio. Considering AstraZeneca’s $64.42 billion in total assets, the debt-ratio is at 0.3. Generally speaking, a debt-ratio more than 1 means that a large portion of debt is funded by assets. As the debt-ratio increases, so the does the risk of defaulting on loans, if interest rates were to increase. Different industries have different thresholds of tolerance for debt-ratios. A debt ratio of 40% might be higher for one industry, whereas average for another.

Why Investors Look At Debt?

Debt is an important factor in the capital structure of a company, and can help it attain growth. Debt usually has a relatively lower financing cost than equity, which makes it an attractive option for executives.

However, due to interest-payment obligations, cash-flow of a company can be impacted. Equity owners can keep excess profit, generated from the debt capital, when companies use the debt capital for its business operations.


Related Articles (AZN)

View Comments and Join the Discussion!

Posted-In: Debt InsightsNews Intraday Update Markets